ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 79 filers reported holding ANTARES PHARMA INC in Q3 2014. The put-call ratio across all filers is 37.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $365,000 | -41.2% | 112,768 | -41.5% | 0.65% | -35.3% |
| Q2 2017 | $621,000 | +220.1% | 192,734 | +181.8% | 1.00% | +260.3% |
| Q1 2017 | $194,000 | +120.5% | 68,386 | +80.8% | 0.28% | +89.7% |
| Q4 2016 | $88,000 | +252.0% | 37,826 | +159.2% | 0.15% | +231.8% |
| Q3 2016 | $25,000 | +25.0% | 14,594 | -24.9% | 0.04% | +37.5% |
| Q2 2016 | $20,000 | +11.1% | 19,421 | +177.4% | 0.03% | +52.4% |
| Q4 2014 | $18,000 | +38.5% | 7,000 | 0.0% | 0.02% | +23.5% |
| Q3 2014 | $13,000 | -86.6% | 7,000 | -80.8% | 0.02% | -87.9% |
| Q2 2014 | $97,000 | -24.2% | 36,500 | 0.0% | 0.14% | -34.3% |
| Q1 2014 | $128,000 | -21.5% | 36,500 | 0.0% | 0.21% | -13.4% |
| Q4 2013 | $163,000 | – | 36,500 | – | 0.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 3,130,192 | $12,834,000 | 5.32% |
| Velan Capital Investment Management LP | 1,346,971 | $5,523,000 | 5.12% |
| FIRST WILSHIRE SECURITIES MANAGEMENT INC | 2,799,953 | $11,480,000 | 4.03% |
| Sargent Investment Group, LLC | 3,663,275 | $15,019,000 | 3.78% |
| PERKINS CAPITAL MANAGEMENT INC | 481,483 | $1,974,000 | 1.62% |
| Rubric Capital Management LP | 10,900,000 | $44,690,000 | 1.62% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,720,000 | $7,052,000 | 1.39% |
| Long Focus Capital Management, LLC | 540,000 | $2,214,000 | 0.28% |
| OBERWEIS ASSET MANAGEMENT INC/ | 344,200 | $1,411,000 | 0.28% |
| FIRETHORN WEALTH PARTNERS, LLC | 84,069 | $345,000 | 0.26% |